Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice

Clinical and Vaccine Immunology

Volumn 14, Issue 3, 2007, Pages 226-233

  Cortes Perez, Naima G ^a,b   Ah Leung, Sandrine ^a   Bermúdez Humarán, Luis G ^b   Corthier, Gérard ^b   Wal, Jean Michel ^a   Langella, Philippe ^b   Adel Patient, Karine ^a,c  

^a Bâtiment 136 CEA de Saclay   (France)

^b CEMAGREF   (France)

^c CEA SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA LACTOGLOBULIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 5; PROBIOTIC AGENT; RECOMBINANT INTERLEUKIN 12;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL STRAIN; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; LACTOCOCCUS LACTIS; LUNG LAVAGE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SENSITIZATION; TH1 CELL;

ADMINISTRATION, INTRANASAL; ANIMALS; CATTLE; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LACTOCOCCUS LACTIS; LACTOGLOBULINS; MICE; MICE, INBRED BALB C; MILK HYPERSENSITIVITY; VACCINES, SYNTHETIC;

EID: 34147157202     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00299-06     Document Type: Article

References (58)

1. Adel-Patient, K., S. Ah-Leung, C. Creminon, S. Nouaille, J. M. Chatel, P. Langella, and J. M. Wal. 2005. Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization. Clin. Exp. Allergy 35:539-546.
2. Adel-Patient, K., M. A. Nahori, B. Proust, J. R. Lapa e Silva, C. Creminon, J. M. Wal, and B. B. Vargaftig. 2003. Elicitation of the allergic reaction in beta-lactoglobulin-sensitized Balb/c mice: biochemical and clinical manifestations differ according to the structure of the allergen used for challenge. Clin. Exp. Allergy 33:376-385.
3. Adel-Patient, K., C. Creminon, D. Boquet, J. M. Wal, and J. M. Chatel. 2001. Genetic immunisation with bovine beta-lactoglobulin cDNA induces a preventive and persistent inhibition of specific anti-BLG IgE response in mice. Int. Arch. Allergy Immunol. 126:59-67.
4. Adel-Patient, K., C. Creminon, H. Bernard, G. Clement, L. Negroni, Y. Frobert, J. Grassi, J. M. Wal, and J. M. Chatel. 2000. Evaluation of a high IgE-responder mouse model of allergy to bovine beta-lactoglobulin (BLG): development of sandwich immunoassays for total and allergen-specific IgE, IgG1 and IgG2a in BLG-sensitized mice. J. Immunol. Methods 235:21-32.
5. Alvarez, D., F. K. Swirski, T. C. Yang, R. Fattouh, K. Croitoru, J. L. Bramson, M. R. Stämpfli, and M. Jordana. 2006. Inhalation tolerance is induced selectively in thoracic lymph nodes but executed pervasively at distant mucosal and non mucosal tissues. J. Immunol. 176:2568-2580.
6. Arulanandam, B. P., M. O'Toole, and D. W. Metzger. 1999. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. J. Infect. Dis. 180:940-949.
7. Arulanandam, B. P., and D. W. Metzger. 1999. Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery. Vaccine 17:252-260.
8. Bermúdez-Humarán, L. G., N. G. Cortes-Perez, F. Lefevre, V. Guimaraes, S. Rabot, J. M. Alcocer-Gonzalez, J. J. Gratadoux, C. Rodriguez-Padilla, R. S. Tamez-Guerra, G. Corthier, A. Gruss, and P. Langella. 2005. A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J. Immunol. 175:7297-7302.
9. Bermúdez-Humarán, L. G., G. Corthier, and P. Langella. 2004. Recent advances in the use of Lactococcus lactis as live recombinant vector for the development of new safe mucosal vaccines. Recent Res. Dev. Microbiol. 8:147-160.
10. Bermúdez-Humarán, L. G., P. Langella, N. G. Cortes-Perez, A. Gruss, R. S. Tamez-Guerra, S. C. Oliveira, O. Saucedo-Cardenas, R. Montes de Oca-Luna, and Y. Le Loir. 2003. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect. Immun. 71:1887-1896.
11. Bjermer, L., and Z. Diamant. 2004. Current and emerging nonsteroidal anti-inflammatory therapies targeting specific mechanisms in asthma and allergy. Treat. Respir. Med. 3:235-246.
12. Charng, Y. C., C. C. Lin, and C. H. Hsu. 2005. Inhibition of allergen-induced airway inflammation and hyperreactivity by recombinant lactic-acid bacteria. Vaccine 24:5931-5936.
13. Chatel, J. M., S. Nouaille, K. Adel-Patient, Y. Le Loir, H. Boe, A. Gruss, J. M. Wal, and P. Langella. 2003. Characterization of a Lactococcus lactis strain that secretes a major epitope of bovine beta-lactoglobulin and evaluation of its immunogenicity in mice. Appl. Environ. Microbiol. 69:6620-6627.
14. Chatel, J. M., P. Langella, K. Adel-Patient, J. Commissaire, J. M. Wal, and G. Corthier. 2001. Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin. Clin. Diagn. Lab. Immunol. 8:545-551.
15. Chretien, I., J. Pene, F. Briere, R. de Waal Malefyt, F. Rousset, and J. E. de Vries. 1990. Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of IL-4 and IFN-gamma. Eur. J. Immunol. 20:243-251.
16. Chun-Keung, Y., L. Yi-Hsia, and C. Chih-Long. 2002. Dehydroepiandrosterone attenuates allergic airway inflammation in Dermatophagoides farinae-sensitized mice. J. Microbiol. Immunol. Infect. 35:199-202.
17. Coffman, R. L., and J. Carty. 1986. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J. Immunol. 136:949.
18. Cohen, J. 1995. IL-12 deaths: explanation and a puzzle. Science 270:908.
19. Drouault, S., G. Corthier, S. D. Ehrlich, and P. Renault. 1999. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl. Environ. Microbiol. 65:4881-4886.
20. Erb, K. J., J. W. Holloway, A. Sobeck, H. Moll, and G. Le Gros. 1998. Infection of mice with Mycobacterium bovis-bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 16:561-569.
21. Eum, S. Y., S. Haile, J. Lefort, M. Huerre, and B. B. Vargaftig. 1995. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc. Natl. Acad. Sci. USA 92:12290-12294.
22. Ford, R. P., D. J. Hill, and C. S. Hosking. 1983. Cows' milk hypersensitivity: immediate and delayed onset clinical patterns. Arch. Dis. Child. 58:856-862.
23. Hanniffy, S., U. Wiedemann, A. Repa, A. Mercenier, C. Daniel J. Fioramonti, H. Tlaskolova, H. Kozakova, H. Israelsen, S. Madsen, A. Vrang, P. Hols, J. Delcour, P. Bron, M. Kleerebezem, and J. Wells. 2004. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv. Appl. Microbiol. 56:1-64.
24. Hefle, S. L., and S. L. Taylor. 2004. Food allergy and the food industry. Curr. Allergy Asthma Rep. 4:55-59.
25. Hill, D. J., M. A. Firer, G. Ball, and C. S. Hosking. 1989. Recovery from milk allergy in early childhood: antibody studies. J. Pediatr. 114:761-766.
26. Huber, V. C., B. P. Arulanandam, P. M. Arnaboldi, M. K. Elmore, C. E. Sheehan, B. V. Kallakury, and D. W. Metzger. 2003. Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity. Int. Immunopharmacol. 3:801-809.
27. Hufnagl, K., B. Winkler, M. Focke, R. Valenta, O. Scheiner, H. Renz, and U. Wiedemann. 2005. Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice. J. Allergy Clin. Immunol. 116:370-376.
28. Johnson, J. R., R. E. Wiley, R. Fattouh, F. K. Swirski, B. U. Gajewska, A. J. Coyle, J. C. Gutierrez-Ramos, R. Ellis, M. D. Inman, and M. Jordana. 2004. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am. J. Respir. Crit. Care Med. 169:378-385.
29. Keller, A. C., D. Mucida, E. Gomes, E. Faquim-Mauro, A. M. Faria, D. Rodriguez, and M. Russo. 2006. Hierarchical suppression of asthma-like responses by mucosal tolerance. J. Allergy Clin. Immunol. 117:283-290.
30. Kimoto, H., M. Nomura, M. Kobayashi, K. Mizumachi, and T. Okamoto. 2003. Survival of lactococci during passage through mouse digestive tract. Can. J. Microbiol. 49:707-711.
31. Leonard, J. P., M. L. Sherman, G. L. Fisher, L. J. Buchanan, G. Larsen, M. B. Atkins, J. A. Sosman, J. P. Dutcher, N. J. Vogelzang, and J. L. Ryan. 1997. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 90:2541-2548.
32. Lotze, M. T., L. Zitvogel, R. Campbell, P. D. Robbins, E. Elder, C. Haluszczak, D. Martin, T. L. Whiteside, W. J. Storkus, and H. Tahara. 1996. Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials. Ann. N. Y. Acad. Sci. 795:440-454.
33. Lui, V. W., L. D. Falo, and L. Huang. 2001. Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo. J. Gene Med. 3:384-393.
34. Maassen, C. B., C. van Holten-Neelen, F. Balk, M. J. den Bak-Glashouwer, R. J. Leer, J. D. Laman, W. J. Boersma, and E. Claassen. 2000. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18:2613-2623.
35. Majamaa, H., and E. Isolauri. 1997. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99:179-185.
36. Matheu, V., O. Back, E. Mondoc, and S. Issazadeh-Navikas. 2003. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J. Allergy Clin. Immunol. 112:585-592.
37. Miettinen, M., J. Vuopio-Varkila, and K. Varkila. 1996. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64:5403-5405.
38. Mohamadzadeh, M., S. Olson, W. V. Kalina, G. Ruthel, G. L. Demmin, K. L. Warfield, S. Bavari, and T. R. Klaenhammer. 2005. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl. Acad. Sci. USA 102:2880-2885.
39. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
40. Motzer, R. J., A. Rakhit, L. H. Schwartz, T. Olencki, T. M. Malone, K. Sandstrom, R. Nadeau, H. Parmar, and R. Bukowski. 1998. Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma. Clin. Cancer Res. 4:1183-1191.
41. Negroni, L., H. Bernard, G. Clement, J. M. Chatel, P. Brune, Y. Frobert, J. M. Wal, and J. Grassi. 1998. Two-site enzyme immunometric assays for determination of native and denatured beta-lactoglobulin. J. Immunol. Methods 220:25-37.
42. Nouaille, S., L. G. Bermúdez-Humarán, K. Adel-Patient, J. Commissaire, A. Gruss, J. M. Wal, V. Azevedo, P. Langella, and J. M. Chatel. 2005. Improvement of bovine ss-lactoglobulin production and secretion by Lactococcus lactis. Braz. J. Med. Biol. Res. 38:353-359.
43. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275-283.
44. + T cells expressing membrane-bound TGF-beta and FOXP3. J. Clin. Investig. 114:28-38.
45. Paludan, S. R. 1998. Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship. Scand. J. Immunol. 48:459-468.
46. Pene, J., F. Rousset, F. Briere, I. Chretien, J. Y. Bonnefoy, H. Spits, T. Yokota, N. Arai, K. I. Arai, J. Banchereau, and J. E. de Vries. 1988. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Natl. Acad. Sci. USA 85:6880-6884.
47. Pochard, P., P. Gosset, C. Grangette, C. Andre, A. B. Tonnel, J. Pestel, and A. Mercenier. 2002. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J. Allergy Clin. Immunol. 110:617-623.
48. Repa, A., C. Grangette, C. Daniel, R. Hochreiter, K. Hoffmann-Sommergruber, J. Thalhamer, D. Kraft, H. Breiteneder, A. Mercenier, and U. Wiedermann. 2003. Mucosal application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 22:87-95.
49. Shibamori, M., K. Ogino, Y. Kambayashi, and H. Ishiyama. 2006. Intranasal mite allergen induces allergic asthma-like responses in NC/Nga mice. Life Sci. 78:987-994.
50. Shida, K., R. Takahashi, E. Iwadate, K. Takamizawa, H. Yasui, T. Sato, S. Habu, S. Hachimura, and S. Kaminogawa. 2002. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin. Exp. Allergy 32:563-570.
51. Skeen, M. J., M. A. Miller, T. M. Shinnick, and H. K. Ziegler. 1996. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 156:1196-1206.
52. Song, F., G. Matsuzaki, M. Mitsuyama, and K. Nomoto. 1996. Differential effects of viable and killed bacteria on IL-12 expression of macrophages. J. Immunol. 156:2979-2984.
53. Swirski, F. K., D. Sajic, C. S. Robbins, B. U. Gajewska, M. Jordana, and M. R. Stampfli. 2002. Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor. J. Immunol. 169:3499-3506.
54. Trinchieri, G. 1995. Interleukin-12: a proinflammatoiy cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
55. Venkataraman, C., S. Leung, A. Salvekar, H. Mano, and U. Schindler. 1999. Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation. J. Immunol. 162:4053-4061.
56. Winkler, B., K. Baier, S. Wagner, A. Repa, H. G. Eichler, O. Scheiner, D. Kraft, and U. Wiedermann. 2002. Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin. Exp. Allergy 32:30-36.
57. Wu, C., G. Yang, L. G. Bermúdez-Humarán, P. Qingfeng, Z. Yinming, J. Wang, and X. Gao. 2006. Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice. Int. Immunopharmacol. 6:610-615.
58. Yasumi, T., K. Katamura, I. Okafuji, T. Yoshioka, T. A. Meguro, R. Nishikomori, T. Kusunoki, T. Heike, and T. Nakahata. 2005. Limited ability of antigen-specific Th1 responses to inhibit Th2 cell development in vivo. J. Immunol. 174:1325-1331.